Gamma-aminobutyric acid type A receptor subunit beta-2 (for β2), Gamma-aminobutyric acid type A receptor subunit beta-3 (for β3) (GABAA receptor β2 (GABRB2), GABAA receptor β3 (GABRB3))

Gamma-aminobutyric acid type A (GABAA) receptor subunit beta-2 and beta-3 are integral components of GABAA receptors, the primary inhibitory neurotransmitter-gated chloride channels in the mammalian central nervous system[1][3][6][7]. Each GABAA receptor is generally a pentamer composed of various combinations of subunits; β2 and β3 are among the most important β subunit isoforms. These β subunits participate in the formation of the central ion channel pore and the GABA binding site at the subunit interface, playing key roles in receptor assembly, gating, chloride selectivity, and pharmacological modulation by numerous clinically important drugs[1][5][7]. Variations in the β2 and β3 subunits have been associated with neurological and psychiatric disorders, making them significant therapeutic targets in epilepsy, anxiety, schizophrenia, and other CNS diseases[7]. Drugs targeting GABAA receptors (and specifically receptors containing β2/β3 subunits) include benzodiazepines, barbiturates, anesthetics, and neurosteroids; these modulate neuronal inhibition by enhancing or altering GABA-induced chloride influx, resulting in sedative, anxiolytic, anticonvulsant, and hypnotic effects[7][9]. Safety issues include sedation, dependence, tolerance, and, in overdose, life-threatening respiratory depression[7]. The β2 and β3 subunits also have roles in receptor pharmacology, allosteric modulation, and structural heterogeneity, influencing the properties of the assembled GABAA receptor[5][6][7].

Other names

GABA(A) receptor beta-2GABA(A) receptor beta-3GABRB2 (for beta-2 subunit)GABRB3 (for beta-3 subunit)GABA(A)R β2, GABA(A)R β3Gamma-aminobutyric acid receptor beta-2, beta-3 subunitCys-loop ligand-gated ion channel beta subunit

Positive allosteric modulation: Enhance GABA-activated chloride current (benzodiazepines, barbiturates, Z-drugs, neurosteroids)[7][9] Direct agonist: Some anesthetics and neurosteroids can directly gate the chloride channel Antagonism/inhibition: Compounds like flumazenil block benzodiazepine modulation; certain convulsants inhibit GABA action Channel opening: GABA binding triggers conformational changes leading to ion channel opening